Danish drugmaker Novo Nordisk plans to invest 650 million krone, or $98 million, to upgrade and expand facilities at its site in Kalundborg. The plants currently manufacture a range of diabetes products but will be rebuilt to allow for future production of next-generation products. Novo Nordisk anticipates completing the project in 2020.
Original Article: Novo Nordisk Upgrades Danish Plant